Company: BLRX
Filing Date: 2025-03-31
Form Type: 20-F
Source: 0001178913-25-001123
Chunk: 154

Company: BioLineRx Ltd.
Filing Date: 2025-03-31
Form: 20-F
Item: Item 3
Chunk 154
---
 or threatened litigation that may result in claims for indemnification by any director or officer.

D. Employees

As of March 16, 2025, we had 24 full-time employees and 4 part-time
employees, all of whom are employed in Israel. Of our employees, 11 hold M. D. or Ph. D. degrees.

                                                  December 31,                          
                                                          2022                          
 ────────────────────────────────────────────────────────────────────────────────────────
  Management and administration                                     12      12       8  
  Research and development                                          29      29      19  
  Commercialization and business development                         8      38       1  
  Total                                                             49      79      28  

While none of our employees are party to any collective bargaining
agreements, in Israel we are subject to certain labor statutes and national labor court precedent rulings, as well as to certain provisions
of the collective bargaining agreements between the Histadrut (General Federation of Labor in Israel) and the Coordination Bureau of Economic
Organizations and/or the Industrialists’ Association which are applicable to our employees by virtue of expansion orders issued
in accordance with relevant labor laws by the Israel Ministry of Labor and Welfare, and which apply such agreement provisions to our employees
even though they are not directly part of a union that has signed a collective bargaining agreement. The laws and labor court rulings
that apply to our employees principally concern the minimum wage laws, procedures for dismissing employees, determination of severance
pay, leaves of absence, sick pay and other conditions for employment. The expansion orders which apply to our employees principally concern
the requirement for length of the workday and work week, mandatory contributions to a pension fund, annual recreation allowance, travel
expenses payment and other conditions of employment. We generally provide our employees with benefits and working conditions beyond the
required minimums.

We have never experienced any employment-related work stoppages
and believe our relationship with our employees is good.

86

E. Share Ownership

See “ Item 7. A. Major Shareholders” below.

Equity Compensation Plan

2003 Amended and Restated Share Incentive Plan

In 2003, we adopted the BioLineRx Ltd. 2003 Share Incentive Plan,
or the Plan. In August 2013, our board of directors approved certain amendments to the Plan and extended the term of the Plan until November
2023, and the Plan was renamed as the BioLine